AI-Designed Thermoelectric Generator Slashes Design Time

Brain-computer interfaces (BCIs) are moving from neuroscience labs toward mainstream medical use, with companies like Neuralink, Synchron, and Blackrock Neurotech leading the charge. Trial participants — paralyzed individuals with spinal cord injuries, ALS, and other conditions — share their experiences using implants to control robotic arms, computers, and even restore speech. While the emotional and practical benefits are profound, significant challenges remain: limited portability, neural drift requiring recalibration, implant durability of roughly a decade, and the psychological risk of losing access after trials end. Newer devices like Neuralink's wireless coin-sized implant and Synchron's stentrode are more user-friendly, with adaptive ML-based decoders reducing recalibration needs. Debate continues over whether BCIs should target consumer markets, with users split on whether commercialization would help or harm medical users.